Ovid Therapeutics Inc. (OVID): Total Assets
$150.93M
As of 2025-12-31
$231.97M
As of 2026-06-30
-0.9%
3-year compound annual growth
+14.7%
5-year compound annual growth
| Period ended | Total Assets | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $150.93M | +63.8% | 2026-03-18, Balance as of period end |
| 2024-12-31 | $92.17M | -36.0% | 2026-03-18, Balance as of period end |
| 2023-12-31 | $144.03M | -7.2% | 2025-03-11, Balance as of period end |
| 2022-12-31 | $155.27M | -20.2% | 2024-03-08, Balance as of period end |
| 2021-12-31 | $194.54M | +156.2% | 2023-03-13, Balance as of period end |
| 2020-12-31 | $75.93M | -6.1% | 2022-03-15, Balance as of period end |
| 2019-12-31 | $80.84M | +69.7% | 2021-03-15, Balance as of period end |
| 2018-12-31 | $47.65M | -46.7% | 2020-03-11, Balance as of period end |
| 2017-12-31 | $89.46M | +68.7% | 2019-03-07, Balance as of period end |
| 2016-12-31 | $53.03M | n/a | 2018-03-29, Balance as of period end |
Total Assets at similar companies
| Company | Year ended | Total Assets | Change YoY |
|---|---|---|---|
| Ovid Therapeutics Inc. (OVID) | 2025-12-31 | $150.93M | +63.8% |
| Whitehawk Therapeutics, Inc. (WHWK) | 2025-12-31 | $150.83M | +114.5% |
| Xenon Pharmaceuticals Inc. (XENE) | 2025-12-31 | $633.16M | -20.7% |
| Immunome Inc. (IMNM) | 2025-12-31 | $683.19M | +184.4% |
| Adagene Inc. (ADAG) | 2025-12-31 | $78.26M | -12.3% |
| Bolt Biotherapeutics, Inc. (BOLT) | 2025-12-31 | $56.75M | -43.0% |
| Aclaris Therapeutics, Inc. (ACRS) | 2025-12-31 | $160.46M | -27.2% |
| Coya Therapeutics, Inc. (COYA) | 2025-12-31 | $49.95M | +12.6% |
| Korro Bio, Inc. (KRRO) | 2025-12-31 | $113.51M | -49.8% |
Compare OVID, WHWK, XENE, IMNM side by side · Screen every company in Pharmaceutical Preparations ↗